share_log

浙大网新(600797.SH):参股公司九源基因拟在香港联交所主板上市

Insigma Technology (600797.SH): Jointly invested company Jiuyuan Genes plans to list on the main board of the Hong Kong Stock Exchange.

Gelonghui Finance ·  Nov 20 06:44

Gelonghui, November 20, 丨 Zhejiang University Wangxin (600797.SH) announced that Hangzhou Jiuyuan Genetic Engineering Co., Ltd. (“Jiuyuan Gene”), a wholly-owned subsidiary of the company, disclosed the prospectus on the Hong Kong Stock Exchange website on November 20, 2024, to carry out a global sale. Among them, the Hong Kong Public Sale section of 4,540,000 H shares (can be redistributed), and the international placement of 40,858,800 H shares (can be redistributed and can be exceeded according to the quota allocation) envoy (Adjusted). The sale price range is HK$11.48-12.56. Heda Jinyuan (Hong Kong) Co., Ltd., Fosun Industrial (Hong Kong) Co., Ltd., Hong Kong Jianyou Industrial Co., Ltd., Ali Health (Hong Kong) Technology Co., Ltd., JoinTownInternationalGroupCompanyLimited, DeltaCapitalHongKong Limited, and Wu Qiyuan acted as cornerstone investors to purchase the number of shares offered for a total subscription amount of approximately HK$0.35 billion. According to the prospectus, Jiuyuan Gene began public sale in Hong Kong on November 20. It is expected that Jiuyuan Gene H shares will begin trading on the main board of the Hong Kong Stock Exchange on November 28, 2024, with the stock code 2566.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment